View Older Stories View More Recent Stories

Apr 20, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 20, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 20, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 15, 2026 04:52PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 15, 2026 04:51PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Apr 14, 2026 02:08PM Galera and Obsidian merge in $350 million all-stock deal
Apr 14, 2026 02:08PM Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
Apr 14, 2026 08:54AM Obsidian Therapeutics and Galera Therapeutics announce merger with $350M funding
Apr 14, 2026 08:54AM Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
Apr 1, 2026 08:00AM Nocion Therapeutics Strengthens Board of Directors with Appointment of Mark Iwicki
Mar 11, 2026 07:00AM Vima Therapeutics Announces First Dystonia Patient Dosed in Phase 2 Study and Extension of Series A to $100 Million to Advance Potential First-in-Class Oral Therapy for Dystonia and Parkinson’s Dise
Mar 2, 2026 05:12PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 2, 2026 05:12PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Feb 24, 2026 08:00AM K36 Therapeutics Highlights First-in-Human KTX-2001 Prostate Cancer Study Design at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2026
Feb 13, 2026 06:01AM Form 13F-HR Atlas Venture Life Scien For: Dec 31
Feb 9, 2026 06:19PM Form 4 Generation Bio Co. For: Feb 09 Filed by: Atlas Venture Opportunity Fund I, L.P.
Feb 5, 2026 10:59AM K36 Therapeutics Completes Dosing of First Cohort in Phase 1 Clinical Trial of KTX-2001 in Prostate Cancer, Announces New CMO
Feb 5, 2026 07:08AM VectorY Therapeutics names Kevin Pojasek to board of directors
Feb 5, 2026 07:08AM VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
Jan 29, 2026 03:19PM Form 13F-NT Atlas Venture Associates For: Dec 31
Jan 29, 2026 03:17PM Form 13F-NT Atlas Venture Associates For: Dec 31
Jan 29, 2026 03:14PM Form 13F-NT Atlas Venture Fund VIII, For: Dec 31
Jan 29, 2026 03:09PM Form 13F-HR Atlas Venture Advisors, For: Dec 31
Jan 14, 2026 07:00AM Caldera Therapeutics Launches with $112.5 Million and Announces First Subjects Dosed in Phase 1 Trial of First-In-Class Bispecific Antibody CLD-423 for Inflammatory Bowel Disease
Jan 10, 2026 11:35AM Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases
Jan 8, 2026 06:30AM Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline
Dec 23, 2025 08:37PM Form SCHEDULE 13G/A INTEGRAL AD SCIENCE HOLD Filed by: Atlas Venture Fund VIII, L.P.
Dec 23, 2025 08:36PM Form 4 INTEGRAL AD SCIENCE HOLD For: Dec 23 Filed by: Atlas Venture Associates VIII, Inc.
Dec 23, 2025 07:30AM Dyne Therapeutics names Vikram Karnani to board of directors
Dec 23, 2025 07:30AM Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
Dec 22, 2025 08:00AM Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease
Dec 17, 2025 08:08PM Form SCHEDULE 13D/A Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Dec 17, 2025 05:08PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund XII, L.P.
Dec 17, 2025 05:07PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Dec 17, 2025 05:07PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Dec 17, 2025 05:06PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Dec 16, 2025 05:18PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund XII, L.P.
Dec 16, 2025 05:18PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Dec 16, 2025 05:17PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Dec 16, 2025 05:16PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Dec 16, 2025 05:15PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Dec 16, 2025 05:04PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Dec 16, 2025 04:59PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Dec 16, 2025 04:57PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Associates XII, L.P.
Dec 15, 2025 06:57PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Dec 15, 2025 06:56PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Dec 15, 2025 06:50PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Dec 15, 2025 06:44PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Associates XII, L.P.
Dec 15, 2025 05:41PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Dec 15, 2025 05:38PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund XII, L.P.
View More Recent Stories View Older Stories